Anthony Chi

Medical Director Kaiser Kermanente

Tony joined the Mid-Atlantic Permanente Medical Group because it offers a diverse patient population and strong support from the laboratory staff. He enjoys anatomic pathology as it provides the opportunity to aid the clinical team in reaching a diagnosis based on tissue biopsy, helping to guide the right treatment plan for patients
Tony heads the molecular testing efforts within KP MAS by testing a select set of cancer-types with a targeted NGS panel as well as integrating molecular profiling in bone marrow and peripheral blood evaluation and reporting.

Seminars

Wednesday 4th February 2026
Panel Discussion: Bridging the Gap from Innovation to Access by Aligning Standardization, Policy & Reimbursement for Liquid Biopsy
12:30 pm
  • Uncovering how inconsistent definitions, metrics, and data standards are hindering payer confidence and policy support for liquid biopsy
  • Exploring the role of pre-competitive collaboration in driving standardization to unlock broader reimbursement and clinical adoption
  • Identifying immediate policy actions and evidence needs to align stakeholders and accelerate access to serial testing and early detection
Anthony Chy - Speaker